We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Experimental Brain Cancer Drug Disrupts Intracellular Endosome Activity

By LabMedica International staff writers
Posted on 16 Mar 2015
Print article
Cancer researchers have described the mechanism by which the low molecular weight compound 5-Benzylglycinyl-amiloride (UCD38B) disrupts the internal regulation of brain cancer (glioma) cells in a manner that triggers the pathway for programmed cell death (apoptosis).

Chemotherapy rarely succeeds in curing brain cancer due to the existence in the tumor of a subpopulation of non-dividing stem cell-like cells that are unaffected by the treatment. These cells, which reside in tumor regions having negligible or no blood supply and minimal oxygen content, remain quiescent for a time then replicate and regenerate the tumor.

Investigators at the University of California, Davis (USA) have been working with the candidate drug UCD38B, which kills both actively growing and quiescent glioma cells. They described the drug's mechanism of action in the January 29, 2015, online issue of the journal Molecular Pharmacology.

The investigators explained that UCD38B triggered an intracellular process of endocytosis that caused 40%–50% of endosomes containing proteins of the urokinase plasminogen activator system (uPAS) to relocate from the area of the cell membrane to mitochondrial regions in the cytoplasm. Components of uPAS have been found to be highly active in many aggressive cancers, including gliomas, as well as metastatic breast, lung, and pancreatic cancers. The improper re-location of the uPAS enzyme complex caused endosomal “mis-trafficking” which corresponded to mitochondrial depolarization with the release and nuclear translocation of apoptosis-inducing factor (AIF) followed by irreversible caspase-independent cell death.

Preliminary studies carried out with a rodent glioma xenograft model showed that a low molecular weight derivative of UCD38B was very effective in destroying the population of hypoxic glioma cells within the tumor without evidence of adverse effects.

“Understanding the drug mechanism of action of UCD38B and its more potent derivatives is the culmination of many years of work of characterizing the processes causing cancer recurrence and developing molecules that target therapeutically resistant cancer cell types,” said senior author Dr. Fredric Gorin, professor of molecular biosciences at the University of California, Davis. “We are hopeful that this new class of drug will one day become an important adjunct to conventional therapies in fighting these especially difficult-to-treat cancers.”

Related Links:

University of California, Davis


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit
New
Newborn Screening Test
NeoMass AAAC 3.0

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.